Allianz Global’s $3.12 Billion Healthcare Sector Stock Positions in Q3

Wall St. Watchdog reveals information regarding Allianz Global Investors of America’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 126 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $3.128 billion.

  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, Allianz Global Investors of America reported holding 19,914,323 shares with a market value of $410,235,061. This comprised 1.14% of the total portfolio. On 09/30/2011, Allianz Global Investors of America reported holding 20,972,130 shares with a market value of $370,787,265. This comprised 1.22% of the total portfolio. The net change in shares for this position over the two quarters is 1,057,807. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Eli Lilly & Co. (NYSE:LLY): On 06/30/2011, Allianz Global Investors of America reported holding 9,455,072 shares with a market value of $354,848,841. This comprised 0.98% of the total portfolio. On 09/30/2011, Allianz Global Investors of America reported holding 8,793,886 shares with a market value of $325,109,976. This comprised 1.07% of the total portfolio. The net change in shares for this position over the two quarters is -661,186. About Company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.
  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, Allianz Global Investors of America reported holding 5,555,748 shares with a market value of $369,568,338. This comprised 1.02% of the total portfolio. On 09/30/2011, Allianz Global Investors of America reported holding 4,984,554 shares with a market value of $317,466,237. This comprised 1.05% of the total portfolio. The net change in shares for this position over the two quarters is -571,194. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Glaxosmithkline Plc (NYSE:GSK): On 06/30/2011, Allianz Global Investors of America reported holding 10,169,938 shares with a market value of $436,290,356. This comprised 1.21% of the total portfolio. On 09/30/2011, Allianz Global Investors of America reported holding 7,198,468 shares with a market value of $297,224,750. This comprised 0.98% of the total portfolio. The net change in shares for this position over the two quarters is -2,971,470. About Company: GlaxoSmithKline plc is a research-based pharmaceutical group that develops, manufactures and markets vaccines, prescription and over-the-counter medicines, as well as health-related consumer products. The Group, which also provides laboratory testing and disease management services, specializes in treatments for respiratory, central nervous system, gastro-intestinal and genetic disorders
  • Sanofi-aventis (NYSE:SNY): On 06/30/2011, Allianz Global Investors of America reported holding 8,796,210 shares with a market value of $353,343,740. This comprised 0.98% of the total portfolio. On 09/30/2011, Allianz Global Investors of America reported holding 8,830,424 shares with a market value of $289,637,900. This comprised 0.95% of the total portfolio. The net change in shares for this position over the two quarters is 34,214. About Company: Sanofi-Aventis is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.
  • Medtronic Inc. (NYSE:MDT): On 06/30/2011, Allianz Global Investors of America reported holding 7,486,505 shares with a market value of $288,455,029. This comprised 0.8% of the total portfolio. On 09/30/2011, Allianz Global Investors of America reported holding 8,366,130 shares with a market value of $278,090,175. This comprised 0.92% of the total portfolio. The net change in shares for this position over the two quarters is 879,625. About Company: Medtronic, Inc. develops therapeutic and diagnostic medical products. The Company’s principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic’s products are sold worldwide.
  • Astrazeneca Plc (NYSE:AZN): On 06/30/2011, Allianz Global Investors of America reported holding 2,717,884 shares with a market value of $136,084,451. This comprised 0.38% of the total portfolio. On 09/30/2011, Allianz Global Investors of America reported holding 2,610,336 shares with a market value of $115,794,507. This comprised 0.38% of the total portfolio. The net change in shares for this position over the two quarters is -107,548. About Company: AstraZeneca PLC is a holding company. Through its subsidiaries, the Group researches, manufactures and sells pharmaceutical and medical products. The Group focuses its operations on seven therapeutic areas: Gastrointestinal, Oncology, Cardiovascular, Respiratory, Central Nervous System, Pain Control, Anaesthesia and Infection.
  • The Cooper Companies Inc. (NYSE:COO): On 06/30/2011, Allianz Global Investors of America reported holding 1,766,003 shares with a market value of $139,938,074. This comprised 0.39% of the total portfolio. On 09/30/2011, Allianz Global Investors of America reported holding 1,368,862 shares with a market value of $108,345,429. This comprised 0.36% of the total portfolio. The net change in shares for this position over the two quarters is -397,141. About Company: The Cooper Companies, Inc. through its subsidiaries, develops, manufactures, and markets specialty healthcare products. The Company’s products include contact lenses for the vision care market and diagnostic products, surgical instruments, and accessories for gynecologists and obstetricians.
  • Teleflex Incorporated (NYSE:TFX): On 06/30/2011, Allianz Global Investors of America reported holding 1,718,366 shares with a market value of $104,923,430. This comprised 0.29% of the total portfolio. On 09/30/2011, Allianz Global Investors of America reported holding 1,621,195 shares with a market value of $87,171,656. This comprised 0.29% of the total portfolio. The net change in shares for this position over the two quarters is -97,171. About Company: Teleflex Incorporated is a global provider of medical technology products. The Company primarily develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications.
  • Steris Corp. (NYSE:STE): On 06/30/2011, Allianz Global Investors of America reported holding 2,637,950 shares with a market value of $92,275,490. This comprised 0.26% of the total portfolio. On 09/30/2011, Allianz Global Investors of America reported holding 2,627,582 shares with a market value of $76,909,326. This comprised 0.25% of the total portfolio. The net change in shares for this position over the two quarters is -10,368. About Company: STERIS Corporation provides sterilization, microbial reduction, and materials modification services to customers throughout the world. The Company’s customers include the medical device, pharmaceutical, biotechnology, food safety, and industrial markets. STERIS also markets a line of cleaning, decontamination, and sterilization systems, products, and technologies.

(Note: Data regarding Allianz Global Investors of America’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>